Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions

Kristina Burow

Moderated Keynote Chat

ARCH Venture Partners

East/West CEO Saturday January 5, 2019
Show Filter
12:00pm - 12:30pm 30 mins
Registration
12:30pm - 1:30pm 60 mins
Keynote Networking Luncheon
1:30pm - 2:00pm 30 mins
2018 Year in Review

A look back at 2018's big developments, trends, non-starters and their implications for 2019

  • Contributor Philippe Lopes-Fernandes - SVP, Global Head of Licensing, BD & Alliance Management, EMD Serono
  • Contributor Tracy Saxton - Executive-In-Residence, Frazier Healthcare Partners
  • Moderator James Sapirstein - Chairman, BioNJ
2:00pm - 2:30pm 30 mins
Adventures in Financing: Raising Capital in 2018

A closer look at some of the influential & interesting financing rounds and the stories behind the science

  • Contributor Emily LeProust - CEO and Co-Founder, Twist Bioscience Corporation
  • Moderator Brian Gallagher, Jr. - Partner, Abingworth
2:30pm - 3:00pm 30 mins
Moderated Keynote Chat
  • Keynote Kristina Burow - Managing Director, ARCH Venture Partners
  • Moderator Wendye Robbins - President and CEO, Blade Therapeutics
3:00pm - 3:30pm 30 mins
Networking Break
3:30pm - 3:50pm 20 mins
Pivoting on a Dime: Spotlight on FLX Bio

What are the operational challenges of re-starting a company after a spin-off? Implications for hiring/retaining key employees, portfolio strategy, brand identity? FLX CEO and COO weighs in on the story behind story, 2017 at FLX, and what lessons you can learn from their transition.

  • Contributor Rekha Hemrajani - Chief Operating Officer, FLX Bio
  • Contributor Brian Wong - CEO, FLX Bio
3:50pm - 4:20pm 30 mins
Asia Biotech Market Outlook

A look at the biotech market in Asia, big developments, regulatory updates and business perspectives from those operating in the space

  • Contributor Sanjeev Redkar - President & CEO, CBT Pharmaceuticals, Inc.
  • Contributor Peter Wirth - Director, Zai Lab Limited
  • Contributor Rui Zhang - Venture Partner, ETP Ventures
4:20pm - 4:35pm 15 mins
Spotlight Speaker: HK IPO Story: Ascletis Pharma

Ascletis’ mission is to become a world-class biotechnology company addressing unmet medical needs in three therapeutic areas: anti-viral, cancer and fatty liver disease, for the patients in China and worldwide.

Led by a management team with deep expertise and a proven track record, we have developed an integrated anti-viral platform covering the entire value chain from discovery and development to manufacturing and commercialization.

  • Contributor Jinzi Wu - CEO, Ascletis
4:35pm - 5:05pm 30 mins
Europe Biotech Market Outlook

An overview of the current biotech landscape in Europe, from financing and talent to trends and latest developments, a discussion to set the stage for Europe CEO 2019

  • Contributor Thomas Lonngren - Former Executive Director, European Medicines Agency
  • Contributor Aram Mangasarian - CEO, NOXXON Pharma AG
  • Contributor Nathalie ter Wengel - European Head Worldwide Business Development, Pfizer
  • Moderator Vanessa King - President and CEO, Virion Biotherapeutics
5:05pm - 5:35pm 30 mins
Closing Keynote
  • William N. Hait - Global Head External Innovation, Johnson & Johnson
5:35pm - 5:45pm 10 mins
Closing Remarks
5:45pm - 6:45pm 60 mins
Cocktail Reception